These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38927672)

  • 1. Polymorphisms in the Dopaminergic Receptor D3 Gene Correlate with Disease Progression Rate in Relapsing-Remitting Multiple Sclerosis Patients.
    Ferrari M; Vecchio D; D'Alfonso S; Gemma A; Marino F; Comi C; Cosentino M
    Genes (Basel); 2024 Jun; 15(6):. PubMed ID: 38927672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A link between promoter polymorphisms of the transforming growth factor β1 (TGFB1) and TGF-β1 receptor II (TGFBR2) genes and relapsing-remitting multiple sclerosis.
    Grigorova A; Trenova A; Stanilova S
    Folia Neuropathol; 2020; 58(4):307-316. PubMed ID: 33480235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arylsulfatase a gene polymorphisms in relapsing remitting multiple sclerosis: genotype-phenotype correlation and estimation of disease progression.
    Baronica KB; Mlinac K; Ozretić D; Vladić A; Bognar SK
    Coll Antropol; 2011 Jan; 35 Suppl 1():11-6. PubMed ID: 21648305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single nucleotide variants around the connective tissue growth factor (CTGF/CCN2) gene and their association with multiple sclerosis risk, disability scores, and rate of disease progression.
    Can Demirdöğen B; Kılıç OO; Karagülle EN; Kalmaz LM; Mungan S
    Neurol Sci; 2022 Jun; 43(6):3867-3877. PubMed ID: 35091888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Single Nucleotide Polymorphisms in the Purinergic Receptor
    Guerini FR; Agliardi C; Bolognesi E; Zanzottera M; Caputo D; Pasanisi MB; Rovaris M; Clerici M
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 7 Receptor Alpha Gene Variants Are Correlated with Gene Expression in Patients with Relapsing-remitting Multiple Sclerosis.
    Sayad A; Omrani MD; Solgi G; Noroozi R; Arsang-Jang S; Inoko H; Taheri M
    Iran J Allergy Asthma Immunol; 2017 Aug; 16(4):338-346. PubMed ID: 28865414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study.
    Pan G; Simpson S; van der Mei I; Charlesworth JC; Lucas R; Ponsonby AL; Zhou Y; Wu F; Taylor BV
    J Neurol Neurosurg Psychiatry; 2016 Nov; 87(11):1204-1211. PubMed ID: 27559181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between multiple sclerosis risk-associated SNPs and relapse and disability--a prospective cohort study.
    Lin R; Taylor BV; Simpson S; Charlesworth J; Ponsonby AL; Pittas F; Dwyer T; van der Mei I
    Mult Scler; 2014 Mar; 20(3):313-21. PubMed ID: 23886828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single nucleotide polymorphisms in the FOXP3 gene are associated with increased risk of relapsing-remitting multiple sclerosis.
    Eftekharian MM; Sayad A; Omrani MD; Ghannad MS; Noroozi R; Mazdeh M; Mirfakhraie R; Movafagh A; Roshanaei G; Azimi T; Inoko H; Taheri M
    Hum Antibodies; 2016; 24(3-4):85-90. PubMed ID: 27792007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Tourette syndrome and the dopamine D3 receptor gene rs6280.
    He F; Zheng Y; Huang HH; Cheng YH; Wang CY
    Chin Med J (Engl); 2015 Mar; 128(5):654-8. PubMed ID: 25698199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic modulation of CD4+CD25(high) regulatory T lymphocytes in multiple sclerosis patients during interferon-β therapy.
    Cosentino M; Zaffaroni M; Trojano M; Giorelli M; Pica C; Rasini E; Bombelli R; Ferrari M; Ghezzi A; Comi G; Livrea P; Lecchini S; Marino F
    Neuroimmunomodulation; 2012; 19(5):283-92. PubMed ID: 22472872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis.
    Gemmati D; Zeri G; Orioli E; De Gaetano FE; Salvi F; Bartolomei I; D'Alfonso S; Dall'osso C; Leone MA; Singh AV; Asselta R; Zamboni P
    BMC Med Genet; 2012 Aug; 13():70. PubMed ID: 22883388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of SHMT1, MAZ, ERG, and L3MBTL3 Gene Polymorphisms with Susceptibility to Multiple Sclerosis.
    Nazari Mehrabani SZ; Shushizadeh MH; Abazari MF; Nouri Aleagha M; Ardalan A; Abdollahzadeh R; Azarnezhad A
    Biochem Genet; 2019 Jun; 57(3):355-370. PubMed ID: 30456721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability.
    Kiselev I; Bashinskaya V; Baulina N; Kozin M; Popova E; Boyko A; Favorova O; Kulakova O
    Mult Scler Relat Disord; 2019 Apr; 29():130-136. PubMed ID: 30711878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution melting curve analysis of polymorphisms within CD58, CD226, HLA-G genes and association with multiple sclerosis susceptibility in a subset of Iranian population: a case-control study.
    Ghavimi R; Alsahebfosoul F; Salehi R; Kazemi M; Etemadifar M; Zavaran Hosseini A
    Acta Neurol Belg; 2020 Jun; 120(3):645-652. PubMed ID: 30128676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T2 lesions and rate of progression of disability in multiple sclerosis.
    Mostert JP; Koch MW; Steen C; Heersema DJ; De Groot JC; De Keyser J
    Eur J Neurol; 2010 Dec; 17(12):1471-5. PubMed ID: 20500805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL12B gene polymorphisms have sex-specific effects in relapsing-remitting multiple sclerosis.
    Miteva L; Trenova A; Slavov G; Stanilova S
    Acta Neurol Belg; 2019 Mar; 119(1):83-93. PubMed ID: 30554348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predisposing role of vitamin D receptor (VDR) polymorphisms in the development of multiple sclerosis: A case-control study.
    Abdollahzadeh R; Fard MS; Rahmani F; Moloudi K; Kalani BS; Azarnezhad A
    J Neurol Sci; 2016 Aug; 367():148-51. PubMed ID: 27423580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variant of
    Chen S; Zhang J; Liu QB; Zhuang JC; Wu L; Xu YF; Li HF; Wu ZY; Xiao BG
    Chin Med J (Engl); 2018 Mar; 131(6):643-647. PubMed ID: 29521285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary evidence for association between schizophrenia and polymorphisms in the regulatory Regions of the ADRA2A, DRD3 and SNAP-25 Genes.
    Lochman J; Balcar VJ; Sťastný F; Serý O
    Psychiatry Res; 2013 Jan; 205(1-2):7-12. PubMed ID: 22940547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.